Japfa Comfeed Indonesia Tbk. vs Merck Tbk. — how do they compare? Japfa Comfeed Indonesia Tbk. trades at Rp2,030 (market cap 23.8T, 8.44M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Japfa Comfeed Indonesia Tbk. is far larger — about 14× Merck Tbk.'s market cap, and Japfa Comfeed Indonesia Tbk. is more actively traded (8.44M versus 37.6K). Which is the better fit depends on your goals.
| JPFA | MERK | |
|---|---|---|
Market Cap | 23.8T | 1.7T |
Volume | 8.44M | 37.6K |
Lot | 84.36K | 376 |
Turnover | 17.08B | 144.47M |
Average Price | 2,024.41 | 3,842.23 |
Value | 17.08B | 144.47M |
Indicative Equilibrium Price | 2,030 | 3,840 |
Indicative Equilibrium Volume | 3.58K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Read more on JPFA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →